Clinical Trials Browser

Motor Activity, Hematologic Neoplasms, Neurotoxicity Syndromes

NCT01445288 2026-02-20

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Diffuse Intrinsic Pontine Glioma, Brain Neoplasms, Ependymoma, Medulloblastoma, Central Nervous System Neoplasms, Germinoma, Neuroectodermal Tumors, Primitive, Neurotoxicity Syndromes

NCT01949662 2026-02-13

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Phase 2 Active not recruiting

93 enrolled 14 charts

Other hematologic neoplasm

Delirium, Hematologic Neoplasms, Neurotoxicity Syndromes

NCT07403812 2026-02-11

Assessing DCog Short for Neurotoxicity in CAR-T

Phase NA Not yet recruiting

40 enrolled

Other hematologic neoplasm

Hematologic Neoplasms, Neurotoxicity Syndromes

NCT07357636 2026-01-28

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors

Recruiting

940 enrolled

Neurotoxicity Syndromes

NCT07333976 2026-01-12

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

Phase 2 Completed

90 enrolled

Peripheral Nervous System Diseases, Neurotoxicity Syndromes

NCT04514029 2026-01-08

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Phase EARLY_PHASE1 Active not recruiting

37 enrolled

Lymphoid

Lymphoma, Neurotoxicity Syndromes

NCT07320950 2026-01-06

Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients

Phase 3 Completed

333 enrolled

Gastrointestinal

Colorectal Neoplasms, Neurotoxicity Syndromes

NCT03696784 2025-12-08

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

Phase 1 Active not recruiting

19 enrolled

Lymphoid

Cytokine Release Syndrome, Immune System Diseases, Immunoproliferative Disorders, Lymphatic Diseases, Lymphoma, Lymphoma, B-Cell, Neurotoxicity Syndromes

NCT05025826 2025-12-02

PROPERTY

Phase NA Active not recruiting

110 enrolled

Gastrointestinal

Stomach Neoplasms, Neurotoxicity Syndromes

NCT04150913 2025-11-25

A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

Phase 2 Completed

15 enrolled 17 charts

Lymphoid

Cytokine Release Syndrome, Lymphoma, Non-Hodgkin, Neurotoxicity Syndromes

NCT00727922 2025-11-20

MnDPDP-K04

Phase 2 Completed

23 enrolled

Neoplasms, Neurotoxicity Syndromes

NCT04583124 2025-11-18

ATENTO

Phase NA Completed

42 enrolled

Breast

Breast Neoplasms, Neurotoxicity Syndromes

NCT00978458 2025-09-08

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

Phase 3 Active not recruiting

540 enrolled

CNS

Astrocytoma, Brain Neoplasms, Glioma, Oligodendroglioma, Central Nervous System Neoplasms, Neurotoxicity Syndromes

NCT06950190 2025-08-12

(ECCPC)

Phase 3 Enrolling by invitation

100 enrolled

Chemotherapy-Related Cognitive Impairment, Neurotoxicity Syndromes, Cognitive Dysfunction

Clinical Trials

CARE-T

Exploratory Study of Effects of Radiation Therapy in Pediatric Patients With Central Nervous System Tumors

Haloperidol and Lorazepam for Delirium in Patients With Advanced Cancer

Assessing DCog Short for Neurotoxicity in CAR-T

Longitudinal Cohort Study of Immune-Related Adverse Events in Solid Tumor Patients Treated With Immune Checkpoint Inhibitors

o Tadalafil for Prevention of Docetaxel-Induced Peripheral Neuropathy in Prostate Cancer

Neurotoxicity Prophylaxis With Intrathecal Dexamethasone and Simvastatin Post Axi-Cel

Neuroprotective Effect of Neurotropin on Chronic OXA-induced Neurotoxicity in Stage II and Stage III CRC Patients

Anti-CD19 CAR-T Cells With Inducible Caspase 9 Safety Switch for B-cell Lymphoma

PROPERTY

A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity

MnDPDP-K04

ATENTO

Radiation Therapy With or Without Temozolomide in Treating Patients With Low-Grade Glioma

(ECCPC)